3 Stocks Insiders Are Scrambling To Buy Before The New Year

StreetAuthority Network

As the fourth quarter comes to an end, company insiders are about to go into a quiet period.

Many companies adhere to a strict no-trading policy between the end of the quarter and the eventual release of quarterly earnings. As a result, a wide range of insiders have been scrambling to make their purchases in recent weeks.

Here's a close look at some of the more notable buying activity. (All insider information supplied by InsiderInsights.com.)

1. Occidental Petroleum (NYSE: OXY)
A pair of insiders acquired a combined 7,000 shares in December of this energy driller at an average price of $92 a share. The purchases came after Occidental posted third-quarter results a month earlier that were solidly ahead of forecasts. But insiders aren't buying on the prospects for further profit momentum, but instead for Occidental's planned financial engineering.

Occidental has identified a range of assets it intends to sell, and much of the proceeds will go toward a share buyback. Merrill Lynch, which rates shares a "buy" with a $130 price target, thinks Occidental can buy back $12-$15 billion in stock over the next few years, which would reduce the share count by 15%-20%.

Formal asset sales are expected to be announced in the first quarter of 2014. Shares currently trade around $94, though Goldman Sachs believes that Occidental is worth around $104 a share, on a purely cash flow potential basis. But when measuring the market value of the company's assets, they think this stock is worth $119 a share. Their $109 price target reflects a partial weighting of each factor.

[More from StreetAuthority.com: Missed Out On 2013's Hot IPO Market? These 3 Stocks Still Hold Value]


2. Atlas Resource Partners (NYSE: ARP)
I like to track the moves of legendary investor Leon Cooperman, who continues to show a very deft investment touch at the ripe young age of 70. Nearly a year ago, I profiled his solid recent track record and the three fresh ideas I focused on -- based on his buying -- subsequently rose 60%-180%.

So I took note of his aggressive recent buying in Atlas Resource Partners. As his firm owns more than 10% of shares outstanding, he qualifies as an insider. Soon after ARP reported disappointing third-quarter results in early November, Cooperman bought another 500,000 shares of ARP at an average price of $19. He now owns roughly 5.3 million shares, according to GuruFocus.com.

View gallery


Like other oil and gas master limited partnerships (MLPs), Atlas Resource Partners has come under pressure in 2013 thanks to a changing interest rate environment and slowing dividend growth. (ARP's dividend likely grew 50% in 2013 but will average 10% growth in 2014 and 2015, according to Morgan Stanley.)

It's pretty clear to see why Cooperman loves this stock: The dividend yield now exceeds 10% and approaches 13% when you use Morgan Stanley's 2015 dividend forecast of $2.67. That's quite enticing, regardless of that the 2014 interest rate picture looks like.


[More from StreetAuthority.com: It's Time For A Reality Check For Natural Gas]
3. Merrimack Pharmaceuticals (Nasdaq: MACK)
It's been a wild ride for this drug development company, as shares plunged and rebounded in 2013. Amidst that recent rebound, six different insiders have been collectively acquiring more than 500,000 shares, at prices ranging from $3.70-$4.80. Shares are now modestly above the high end of that buying range.

View gallery


Merrimack has a drug, MM-398, which treats pancreatic cancer in Phase III clinical trials, though investors may know it better for another drug, MM-121, which delivered subpar clinical data earlier this year.

MM-398 appears to be meeting a better fate. Fully one-quarter of patients using the drug have survived, which is a high percentage when you consider that late-stage pancreatic cancer is almost always quickly lethal.

Frankly, it's a bit hard to get a completely clear read on the key strengths of Merrimack's drug pipeline. Brean Murray's analysts think MM-398 is the drug to watch, and could serve as the nearest catalyst. Yet Merrill Lynch is still pretty high on MM-121, assigning a $3 a share value to that drug alone (and just $1 a share to MM-398).

While Merrill thinks that MM-398 -- if approved -- would target a $200-$300 million annual market, MM-121, if approved, would see a market that is twice as big. Merrimack has another drug, MM-111, that faces a $2 billion market opportunity tackling breast cancer, but that drug is too early in development for investors to get too excited about just yet.

Regardless of which drug is the catalyst, insiders clearly think one or several of these drugs will prove themselves through the clinical trials.

Risks to Consider: Insiders are lousy market timers, so if you choose to follow their lead, have a suitably long-time horizon.

[More from StreetAuthority.com: Are Short Sellers Finally Making Headway?]

Action to Take --> Insiders have a better read on their company's fundamentals and when they commit their own funds to acquire shares, investors should take note and perform further research.

Other companies with significant recent insider buying include:

•  Ballantyne Strong (AMEX: BTN)
•  Columbia Property Trust (NYSE: CXP)
•  Horizon Pharma (Nasdaq: HZNP)
•  Fifth Street Finance Corp. (NYSE: FSC)
•  LNB Bancorp (Nasdaq: LNBB)
•  RLJ Entertainment (Nasdaq: RLJE)
•  Corporate Office Properties Trust (NYSE: OFC)
•  SAExploration Holdings (Nasdaq: SAEX)
•  Gulfmark Offshore (NYSE: GLF)

Related Articles


View Comments (0)

Recommended for You


    Argentina's stock market is tanking after the...

    Business Insider
  • Airbus adamant no room for more talks in cancelled Japan jet deal

    Airbus on Thursday said its decision to cancel a $2.2 billion jet order from Skymark Airlines was final, rejecting the Japanese carrier's suggestion that talks were still ongoing. The European aircraft maker said this week it had informed Skymark that its purchase of six A380 superjumbos "has been…

  • Record up to 6 shows at once with FiOS Quantum TV

    Get superior entertainment with FiOS TV, Internet & Phone at a great price & a Free Upgrade to FiOS Quantum TV-Enhanced Service with 2/yr. agreement.

    AdChoicesVerizon FiOSSponsored
  • In San Francisco real estate, $1M won't buy much

    SAN FRANCISCO (AP) — San Francisco Association of Realtors President Betty Taisch has two words of advice for those who want to live here and think $1 million will buy them their dream house: Think again.

    Associated Press
  • Obama to GOP: 'Stop just hating all the time'

    KANSAS CITY, Mo. (AP) — Pointing the finger at Republicans for congressional inaction, President Barack Obama chided lawmakers Wednesday for spending the waning days before their month-long summer break trying to sue him rather than addressing economic issues that could boost the middle class.

    Associated Press
  • Tesla posts 2Q loss, prepares Nevada factory site

    PALO ALTO, Calif. (AP) — Electric car maker Tesla Motors widened its loss in the second quarter as it prepared for the launch of a new SUV and started work on a massive new battery plant.

    Associated Press
  • US warns against traveling to Ebola-hit countries

    NEW YORK (AP) — U.S. health officials on Thursday warned Americans not to travel to the three West African countries hit by an outbreak of Ebola.

    Associated Press
  • 3D Systems Shares Are Cratering

    Shares in 3D Systems were down more than 12% in...

    Business Insider
  • 4 Unusual Savings Strategies That Really Work

    It's just one of those facts of life: Saving money can be really hard. If you're trying to save and not getting ahead, it might be time to try one of these easy, everyday savings habits that will help you tighten your finances.

    U.S.News & World Report LP
  • Make Your Passion a Reality with Capella

    Master the skills you need to work in the field you love. Learn more today.

    AdChoicesCapella UniversitySponsored
  • What SunPower Earnings Mean for First Solar and SolarCity

    After markets close Thursday, solar panel maker SunPower will report second-quarter results. Competitors First Solar and SolarCity are scheduled to report results next week.

    24/7 Wall St.
  • Play

    Why Do Millennials Prefer Cash to Investing Money?

    In the last year, the S&P 500 delivered 17% and cash investments delivered 1%. Which would you rather have? In a Bankrate study, millennials said they'd rather have the cash. The Mutual Fund Store's Senior Vice President of Investments Andy Smith joins Simon Constable on the News Hub to discuss.…

    WSJ Live
  • Wisconsin Supreme Court upholds 2011 union law

    MADISON, Wis. (AP) — The fight over Wisconsin Gov. Scott Walker's signature policy achievement, a law effectively ending collective bargaining for most public employees, ended Thursday with the state Supreme Court declaring it to be constitutional.

    Associated Press
  • Sanctions will damage Russia if not lifted quickly

    MOSCOW (AP) — U.S. and European sanctions against Russia's energy and finance sectors are strong enough to cause deep, long-lasting damage within months unless Moscow persuades the West to repeal them by withdrawing support for Ukrainian insurgents.

    Associated Press
  • Adidas shares plunge 13% after Russia warning

    Adidas shares tanked more than 13 percent after it cut its profit targets for 2014, warning "tensions" in Russia would hit its bottom line.

  • Bank of America ordered to pay $1.27 billion for 'Hustle' fraud

    By Jonathan Stempel NEW YORK (Reuters) - A federal judge on Wednesday ordered Bank of America Corp to pay a $1.27 billion penalty for fraud over shoddy mortgages sold by the former Countrywide Financial Corp. U.S. District Judge Jed Rakoff in Manhattan ruled after a jury last October found the…

  • A 2014 IIHS Top Safety Pick

    Your safety is our priority. Advanced safety features are available on the new 2015 Mazda6. Learn more today!

    AdChoicesMazda USASponsored
  • Play

    Tesla's Earnings: What to Watch For

    Electric-car maker Tesla is scheduled to be released after the bell Thursday, and Mike Ramsey joins MoneyBeat with Paul Vigna to preview the results.

    WSJ Live
  • Why You Should Prepare for the Next Bear Market Now

    The stock market is going gangbusters these days, with the S&P 500 close to surpassing 2,000 points. While the index may never fall back to that level, bear markets will one day hit us hard again. It's a good idea to develop a plan for the next bear market now, while your asset values aren't free…

    U.S.News & World Report LP
  • 5 Little-Known Ways to Boost Your Retirement Savings

    Saving for retirement is no easy task. Fortunately, we have several tools and strategies that can help us reach our retirement goals. Maintain your asset allocation. When you begin investing you typically select an asset allocation that suits your risk tolerance and investment goals.

    U.S.News & World Report LP
  • Panasonic, Tesla to build giant battery plant in US

    Japanese electronics giant Panasonic and US electric vehicle maker Tesla Motors said Thursday they will jointly build and operate a huge lithium ion battery plant known as the Gigafactory. Under the deal, Tesla will run the operations at the proposed US-based plant, while its Japanese partner will…

  • Alcatel-Lucent cuts losses but shares slump

    Telecommunication equipment group Alcatel-Lucent said Thursday it cut net losses by more than half in the second quarter as it battles to rebuild after years of setbacks. Alcatel-Lucent said its quarterly net loss was 298 million euros ($399 million), down from 885 million euros for the same period…

  • Analyst’s Four Gold Miner Takeover Targets May Include a Gigantic Winner

    A new research report from Cowen suggests that some of the senior gold miners are looking to make acquisitions now and will make the play to acquire some of the undervalued developers.

    24/7 Wall St.
  • Get more listings

    Tried every way to get more listings? Here are 10 client capturing secrets revealed.